weekly dose of tirzepatide Medical Weight Loss Education Materials Tirzepatide Dosing - A Patient

Explore the science, ingredients, benefits, safety, and what current research really says before trying them

Weeks 4-8 Trials titrated to 5mg

Tirzepatide was associated with lower all-cause mortality and fewer adverse gastrointestinal events than semaglutide in a large global cohort, researchers reported in a poster at Digestive Disease Week (DDW) 2026

What the Research Shows A 2022 study published in the New England Journal of Medicine (Jastreboff et al.) found that adults with obesity receiving tirzepatide 15 mg lost an average of 20.9% of their body weight over 72 weeks, compared to 3.1% in the placebo group

You are still appropriately hungry and will eat about 1/3-1/2 less food a day